Primecap Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.5M | Sell |
266,870
-20
| -0% | -$3.56K | 0.04% | 191 |
|
|
2026
Q1 | $46M | Hold |
266,890
| – | – | 0.04% | 195 |
|
|
2025
Q4 | $53.2M | Sell |
266,890
-3,650
| -1% | -$662K | 0.04% | 190 |
|
|
2025
Q3 | $42.3M | Sell |
270,540
-60
| -0% | -$9.53K | 0.03% | 203 |
|
|
2025
Q2 | $41.1M | Sell |
270,600
-2,290
| -0.8% | -$305K | 0.03% | 204 |
|
|
2025
Q1 | $41.1M | Sell |
272,890
-90
| -0% | -$15.1K | 0.03% | 198 |
|
|
2024
Q4 | $50.4M | Sell |
272,980
-640
| -0.2% | -$123K | 0.04% | 188 |
|
|
2024
Q3 | $53.9M | Sell |
273,620
-110
| -0% | -$22.9K | 0.04% | 181 |
|
|
2024
Q2 | $56.5M | Sell |
273,730
-200
| -0.1% | -$45.3K | 0.04% | 179 |
|
|
2024
Q1 | $74.2M | Hold |
273,930
| – | – | 0.06% | 160 |
|
|
2023
Q4 | $64.8M | Hold |
273,930
| – | – | 0.05% | 167 |
|
|
2023
Q3 | $53.7M | Sell |
273,930
-50
| -0% | -$10.3K | 0.05% | 176 |
|
|
2023
Q2 | $57.6M | Hold |
273,980
| – | – | 0.05% | 169 |
|
|
2023
Q1 | $55.3M | Sell |
273,980
-10,760
| -4% | -$2.44M | 0.05% | 171 |
|
|
2022
Q4 | $62M | Sell |
284,740
-10,080
| -3% | -$2.2M | 0.06% | 162 |
|
|
2022
Q3 | $58M | Sell |
294,820
-1,040
| -0.4% | -$225K | 0.06% | 165 |
|
|
2022
Q2 | $63.3M | Sell |
295,860
-29,030
| -9% | -$7.09M | 0.06% | 160 |
|
|
2022
Q1 | $92.3M | Sell |
324,890
-32,890
| -9% | -$10.1M | 0.07% | 157 |
|
|
2021
Q4 | $135M | Sell |
357,780
-7,040
| -2% | -$2.74M | 0.09% | 140 |
|
|
2021
Q3 | $151M | Sell |
364,820
-690
| -0.2% | -$287K | 0.11% | 130 |
|
|
2021
Q2 | $135M | Sell |
365,510
-4,750
| -1% | -$1.59M | 0.09% | 141 |
|
|
2021
Q1 | $107M | Sell |
370,260
-170
| -0% | -$47.3K | 0.07% | 150 |
|
|
2020
Q4 | $92.6M | Sell |
370,430
-1,070
| -0.3% | -$255K | 0.07% | 153 |
|
|
2020
Q3 | $84.1M | Sell |
371,500
-5,100
| -1% | -$1.06M | 0.07% | 148 |
|
|
2020
Q2 | $65.7M | Sell |
376,600
-1,500
| -0.4% | -$239K | 0.06% | 159 |
|
|
2020
Q1 | $47.7M | Sell |
378,100
-4,100
| -1% | -$615K | 0.05% | 160 |
|
|
2019
Q4 | $58.4M | Sell |
382,200
-1,400
| -0.4% | -$194K | 0.04% | 166 |
|
|
2019
Q3 | $50.8M | Sell |
383,600
-11,400
| -3% | -$1.53M | 0.04% | 168 |
|
|
2019
Q2 | $56M | Sell |
395,000
-9,000
| -2% | -$1.22M | 0.04% | 171 |
|
|
2019
Q1 | $58.7M | Sell |
404,000
-100
| -0% | -$13.1K | 0.04% | 173 |
|
|
2018
Q4 | $45.7M | Sell |
404,100
-17,000
| -4% | -$2.13M | 0.04% | 178 |
|
|
2018
Q3 | $56.7M | Sell |
421,100
-3,000
| -0.7% | -$370K | 0.04% | 176 |
|
|
2018
Q2 | $47.6M | Sell |
424,100
-200
| -0% | -$21.6K | 0.04% | 182 |
|
|
2018
Q1 | $45.3M | Sell |
424,300
-1,600
| -0.4% | -$172K | 0.03% | 181 |
|
|
2017
Q4 | $46.6M | Sell |
425,900
-300
| -0.1% | -$32.6K | 0.04% | 179 |
|
|
2017
Q3 | $46M | Sell |
426,200
-26,800
| -6% | -$2.75M | 0.04% | 177 |
|
|
2017
Q2 | $45.8M | Sell |
453,000
-421,000
| -48% | -$38.8M | 0.04% | 183 |
|
|
2017
Q1 | $78.6M | Sell |
874,000
-1,000
| -0.1% | -$84.9K | 0.07% | 147 |
|
|
2016
Q4 | $66.7M | Sell |
875,000
-34,660
| -4% | -$2.63M | 0.07% | 142 |
|
|
2016
Q3 | $75.8M | Sell |
909,660
-61,000
| -6% | -$5.11M | 0.08% | 139 |
|
|
2016
Q2 | $80M | Sell |
970,660
-242,500
| -20% | -$20M | 0.09% | 134 |
|
|
2016
Q1 | $92.1M | Sell |
1,213,160
-58,222
| -5% | -$4.31M | 0.1% | 135 |
|
|
2015
Q4 | $102M | Sell |
1,271,382
-165,978
| -12% | -$12M | 0.1% | 126 |
|
|
2015
Q3 | $91.3M | Sell |
1,437,360
-184,940
| -11% | -$13.3M | 0.1% | 135 |
|
|
2015
Q2 | $114M | Hold |
1,622,300
| – | – | 0.11% | 132 |
|
|
2015
Q1 | $129M | Sell |
1,622,300
-70,300
| -4% | -$5.19M | 0.13% | 123 |
|
|
2014
Q4 | $108M | Sell |
1,692,600
-200
| -0% | -$12.5K | 0.11% | 127 |
|
|
2014
Q3 | $101M | Sell |
1,692,800
-4,000
| -0.2% | -$229K | 0.11% | 122 |
|
|
2014
Q2 | $90.8M | Sell |
1,696,800
-1,000
| -0.1% | -$54.9K | 0.1% | 134 |
|
|
2014
Q1 | $102M | Hold |
1,697,800
| – | – | 0.12% | 124 |
|
|
2013
Q4 | $90.1M | Hold |
1,697,800
| – | – | 0.11% | 124 |
|
|
2013
Q3 | $78.5M | Buy |
1,697,800
+57,900
| +4% | +$2.66M | 0.1% | 126 |
|
|
2013
Q2 | $67.3M | Buy |
+1,639,900
| New | +$70.3M | 0.1% | 126 |
|
Other funds holding CRL
AI
Primecap Management's CRL Position: Q2 2026 in Review
Primecap Management reduced its Charles River Laboratories (CRL) stake by 0.01% in Q2 2026, selling an estimated $3.56K and leaving 266,870 shares worth $60.5M. The position accounts for 0.04% of the portfolio, ranked #191.
Primecap Management first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $151M in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Primecap Management held 266,870 shares of Charles River Laboratories worth $60.5M as of Q2 2026.
- Primecap Management sold 20 Charles River Laboratories shares in Q2 2026, an estimated $3.56K.
- Charles River Laboratories made up 0.04% of Primecap Management's portfolio in Q2 2026, its #191 holding.
- Primecap Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Primecap Management's Charles River Laboratories position peaked at $151M in Q3 2021.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.